425 related articles for article (PubMed ID: 24951231)
1. Subtype differentiation of renal cell carcinoma using diffusion-weighted and blood oxygenation level-dependent MRI.
Choi YA; Kim CK; Park SY; Cho SW; Park BK
AJR Am J Roentgenol; 2014 Jul; 203(1):W78-84. PubMed ID: 24951231
[TBL] [Abstract][Full Text] [Related]
2. Diffusion-weighted MRI in renal cell carcinoma: a surrogate marker for predicting nuclear grade and histological subtype.
Goyal A; Sharma R; Bhalla AS; Gamanagatti S; Seth A; Iyer VK; Das P
Acta Radiol; 2012 Apr; 53(3):349-58. PubMed ID: 22496427
[TBL] [Abstract][Full Text] [Related]
3. Renal cell carcinoma: diffusion-weighted MR imaging for subtype differentiation at 3.0 T.
Wang H; Cheng L; Zhang X; Wang D; Guo A; Gao Y; Ye H
Radiology; 2010 Oct; 257(1):135-43. PubMed ID: 20713607
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Utility of Histogram Apparent Diffusion Coefficient and R2* for Differentiation of Low-Grade From High-Grade Clear Cell Renal Cell Carcinoma.
Zhang YD; Wu CJ; Wang Q; Zhang J; Wang XN; Liu XS; Shi HB
AJR Am J Roentgenol; 2015 Aug; 205(2):W193-201. PubMed ID: 26204307
[TBL] [Abstract][Full Text] [Related]
5. Combined diffusion-weighted, blood oxygen level-dependent, and dynamic contrast-enhanced MRI for characterization and differentiation of renal cell carcinoma.
Notohamiprodjo M; Staehler M; Steiner N; Schwab F; Sourbron SP; Michaely HJ; Helck AD; Reiser MF; Nikolaou K
Acad Radiol; 2013 Jun; 20(6):685-93. PubMed ID: 23664397
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of diffusion-weighted imaging in the evaluation of renal masses.
Sandrasegaran K; Sundaram CP; Ramaswamy R; Akisik FM; Rydberg MP; Lin C; Aisen AM
AJR Am J Roentgenol; 2010 Feb; 194(2):438-45. PubMed ID: 20093607
[TBL] [Abstract][Full Text] [Related]
7. Differential diagnosis of the small renal masses: role of the apparent diffusion coefficient of the diffusion-weighted MRI.
Mytsyk Y; Dutka I; Yuriy B; Maksymovych I; Caprnda M; Gazdikova K; Rodrigo L; Kruzliak P; Illjuk P; Farooqi AA
Int Urol Nephrol; 2018 Feb; 50(2):197-204. PubMed ID: 29230706
[TBL] [Abstract][Full Text] [Related]
8. Pseudotumours in chronic kidney disease: can diffusion-weighted MRI rule out malignancy.
Goyal A; Sharma R; Bhalla AS; Gamanagatti S; Seth A
Eur J Radiol; 2013 Nov; 82(11):1870-6. PubMed ID: 23932396
[TBL] [Abstract][Full Text] [Related]
9. Renal cell carcinoma: applicability of the apparent coefficient of the diffusion-weighted estimated by MRI for improving their differential diagnosis, histologic subtyping, and differentiation grade.
Mytsyk Y; Dutka I; Borys Y; Komnatska I; Shatynska-Mytsyk I; Farooqi AA; Gazdikova K; Caprnda M; Rodrigo L; Kruzliak P
Int Urol Nephrol; 2017 Feb; 49(2):215-224. PubMed ID: 27853915
[TBL] [Abstract][Full Text] [Related]
10. Utility of the apparent diffusion coefficient for distinguishing clear cell renal cell carcinoma of low and high nuclear grade.
Rosenkrantz AB; Niver BE; Fitzgerald EF; Babb JS; Chandarana H; Melamed J
AJR Am J Roentgenol; 2010 Nov; 195(5):W344-51. PubMed ID: 20966299
[TBL] [Abstract][Full Text] [Related]
11. Renal cell carcinoma: dynamic contrast-enhanced MR imaging for differentiation of tumor subtypes--correlation with pathologic findings.
Sun MR; Ngo L; Genega EM; Atkins MB; Finn ME; Rofsky NM; Pedrosa I
Radiology; 2009 Mar; 250(3):793-802. PubMed ID: 19244046
[TBL] [Abstract][Full Text] [Related]
12. Use of DWI in the Differentiation of Renal Cortical Tumors.
Hötker AM; Mazaheri Y; Wibmer A; Zheng J; Moskowitz CS; Tickoo SK; Russo P; Hricak H; Akin O
AJR Am J Roentgenol; 2016 Jan; 206(1):100-5. PubMed ID: 26700340
[TBL] [Abstract][Full Text] [Related]
13. Textural differences in apparent diffusion coefficient between low- and high-stage clear cell renal cell carcinoma.
Kierans AS; Rusinek H; Lee A; Shaikh MB; Triolo M; Huang WC; Chandarana H
AJR Am J Roentgenol; 2014 Dec; 203(6):W637-44. PubMed ID: 25415729
[TBL] [Abstract][Full Text] [Related]
14. Subtype Differentiation of Small (≤ 4 cm) Solid Renal Mass Using Volumetric Histogram Analysis of DWI at 3-T MRI.
Li A; Xing W; Li H; Hu Y; Hu D; Li Z; Kamel IR
AJR Am J Roentgenol; 2018 Sep; 211(3):614-623. PubMed ID: 29812980
[TBL] [Abstract][Full Text] [Related]
15. Assessment of renal lesions with blood oxygenation level-dependent MRI at 3 T: preliminary experience.
Min JH; Kim CK; Park BK; Kim E; Kim B
AJR Am J Roentgenol; 2011 Sep; 197(3):W489-94. PubMed ID: 21862777
[TBL] [Abstract][Full Text] [Related]
16. Utility of MRI features in differentiation of central renal cell carcinoma and renal pelvic urothelial carcinoma.
Wehrli NE; Kim MJ; Matza BW; Melamed J; Taneja SS; Rosenkrantz AB
AJR Am J Roentgenol; 2013 Dec; 201(6):1260-7. PubMed ID: 24261365
[TBL] [Abstract][Full Text] [Related]
17. Performance of Relative Enhancement on Multiphasic MRI for the Differentiation of Clear Cell Renal Cell Carcinoma (RCC) From Papillary and Chromophobe RCC Subtypes and Oncocytoma.
Young JR; Coy H; Kim HJ; Douek M; Lo P; Pantuck AJ; Raman SS
AJR Am J Roentgenol; 2017 Apr; 208(4):812-819. PubMed ID: 28125273
[TBL] [Abstract][Full Text] [Related]
18. Application of ADC measurement in characterization of renal cell carcinomas with different pathological types and grades by 3.0T diffusion-weighted MRI.
Yu X; Lin M; Ouyang H; Zhou C; Zhang H
Eur J Radiol; 2012 Nov; 81(11):3061-6. PubMed ID: 22651905
[TBL] [Abstract][Full Text] [Related]
19. Diffusion-weighted imaging versus contrast-enhanced MR imaging for the differentiation of renal oncocytomas and chromophobe renal cell carcinomas.
Zhong Y; Wang H; Shen Y; Guo A; Wang J; Kang S; Ma L; Pan J; Ye H
Eur Radiol; 2017 Dec; 27(12):4913-4922. PubMed ID: 28631081
[TBL] [Abstract][Full Text] [Related]
20. Diffusion-weighted MR imaging in the evaluation of renal tumours.
Squillaci E; Manenti G; Di Stefano F; Miano R; Strigari L; Simonetti G
J Exp Clin Cancer Res; 2004 Mar; 23(1):39-45. PubMed ID: 15149149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
